Vasoactive enzymes and blood flow responses to passive and active exercise in peripheral arterial disease
- a School of Health and Sport Sciences, University of the Sunshine Coast, Sippy Downs, Queensland, Australia
- b Department of Nutrition, Exercise and Sports, University of Copenhagen, Denmark
- c School of Medicine, Royal Brisbane and Women's Hospital, University of Queensland, Herston, Queensland, Australia
- d Sunshine Vascular Surgery and Imaging, Buderim, Queensland, Australia
- Received 8 October 2015, Revised 2 December 2015, Accepted 21 December 2015, Available online 24 December 2015
Passive movement hyperaemia was low in PAD suggesting low nitric oxide availability.
Leg blood flow during exercise correlated with leg muscle prostacyclin synthase.
NADPH oxidase is elevated and leg blood flow is reduced in PAD compared to control.
Peripheral arterial disease (PAD) is characterised by impaired leg blood flow, which contributes to claudication and reduced exercise capacity. This study investigated to what extent vasoactive enzymes might contribute to altered blood flow in PAD (Fontaine stage II).
We compared femoral artery blood flow during reactive hyperaemia, leg-extension exercise and passive leg movement, and determined the level of vasoactive enzymes in skeletal muscle samples from the vastus lateralis in PAD (n = 10, 68.5 ± 6.5 years) and healthy controls (CON, n = 9, 62.1 ± 12.3 years). Leg blood flow was measured with Doppler ultrasound and muscle protein levels of phosphorylated endothelial nitric oxide synthase, NADPH oxidase, cyclooxygenase 1 and 2, thromboxane synthase, and prostacyclin synthase were determined.
Leg blood flow during the initial 90 s of passive leg movement (242 ± 33 vs 441 ± 75 ml min−1, P = 0.03) and during reactive hyperaemia (423 ± 100 vs 1255 ± 175 ml min−1, P = 0.002) was lower in PAD than CON, whereas no significant difference was observed for leg blood flow during exercise (1490 ± 250 vs 1887 ± 349 ml min−1, P = 0.37). PAD had higher NADPH oxidase than CON (1.04 ± 0.19 vs 0.50 ± 0.06 AU, P = 0.02), with no differences for other enzymes. Leg blood flow during exercise was correlated with prostacyclin synthase (P = 0.001).
Elevated NADPH oxidase indicates that oxidative stress may be a primary cause of low nitric oxide availability and impaired blood flow in PAD.
- Peripheral arterial disease;
- Leg blood flow;
- Vasoactive enzymes;
- NADPH oxidase
- AUC, area under the curve;
- COX, cyclooxygenase;
- eNOS, endothelial nitric oxide synthase;
- GAPDH, glyceraldehyde 3-phosphase dehydrogenase;
- NADPH, nicotinamide adenine dinucleotide phosphate;
- NO, nitric oxide;
- PAD, peripheral arterial disease;
- ROS, reactive oxygen species
Peripheral arterial disease (PAD) is characterised by reduced blood flow to the legs attributed to atherosclerotic lesions leading to stenosis and/or occlusion of the conduit arteries . Typically, PAD patients who experience intermittent claudication have impaired muscle function and reduced exercise tolerance that limits daily physical activities  and . While alterations in muscle morphology and metabolism are believed to contribute to these functional impairments, it is likely that the limb blood flow limitation is the primary cause of this impairment . However, the extent to which limb blood flow is limited during leg exercise, and any contribution of endothelial dysfunction and the vasodilating systems, has not been established in PAD.
A recently developed test for the assessment of nitric oxide (NO) dependent vascular function is that of femoral blood flow response to passive movement of the lower leg . Previous studies have shown that both aged individuals and individuals with PAD show a lower blood flow response to passive movement suggesting impaired NO function  and . Similarly, reactive hyperaemia, which is also highly dependent on NO  and , is lower in the aged and in PAD compared to young healthy individuals . This raises questions about the control of blood flow in PAD and presents the possibility that in addition to arterial stenosis, altered NO availability, and thereby limited vasodilation, might contribute to the impairment in leg blood flow of PAD patients during exercise.
Nitric oxide is a critical agent in the control of blood flow to skeletal muscle  and . It is well established that NO availability declines with age  and  and can be further compromised by the presence of atherosclerotic disease, as observed in PAD . However, the cause for low NO availability in PAD is unknown. Generally, NO availability is dependent on the amount of endothelial nitric oxide synthase (eNOS) protein, the state of activation of the enzyme, and the presence of reactive oxygen species (ROS)  and . ROS reduce NO bioavailability by readily reacting with NO to form peroxynitrite, but ROS can also uncouple eNOS whereby the enzyme forms superoxide ions instead of NO . One of the main contributors to ROS in the vasculature is NADPH oxidase and several inflammatory conditions and disease states have been associated with increased NADPH oxidase levels  and , but its expression in skeletal muscle of PAD patients is not known.
Although NO is known to be important for vascular function, other vasoactive systems, both vasodilating and constricting, are known to contribute to vascular conductance in skeletal muscle  and . During exercise, blockade studies in healthy individuals demonstrate that NO and prostaglandins are interdependent vasodilating systems that can compensate for each other to maintain blood flow when one system is compromised  and . This interaction may be acute, but there are also indications of more chronic redundancy between the systems; for example in diabetes and in hypertension, NO availability is low and vascular function is maintained by elevated levels of prostacyclin  and . The impact of PAD on the prostaglandin system is unknown.
Thus, the aims of this study were: 1) to establish femoral arterial blood flow responses in PAD patients compared to healthy controls during reactive hyperaemia, passive leg movement, and active knee extensor exercise; 2) to compare the amounts of vasoactive enzymes in the vastus lateralis muscle in PAD patients and healthy controls, and 3) to explore the relationships between levels of vasoactive enzymes and the blood flow responses.